Delivery Order SPE2DB22D2211-SPE2DB24FNVR2

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,046.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. This delivery order has a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to provide pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The $1,451.30 award has an ultimate completion date of April 8, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp as the sole contractor. The IDC serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml. The contract has a ceiling value of $10,190.52 and a period of performance through September 12, 2024. This delivery order is placed against a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
The Defense Logistics Agency (DLA) awarded a $1,916.65 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which enables the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
The U.S. Defense Logistics Agency (DLA) awarded a $1,741.62 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4564605282 OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical product to the government. This delivery order contract is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply OZEMPIC 0.25-0.5MG 1S pharmaceutical products. The contract has a period of performance through March 5, 2024 and a potential value of $1,161.08. This delivery order is issued under Amerisourcebergen Drug Corp's single award indefinite delivery contract (IDC) with DLA, which has a potential value...
The Defense Logistics Agency (DLA) awarded a $24,859.14 firm-fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support military treatment...
The Defense Logistics Agency (DLA) awarded a $7,298.44 firm fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office division for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products. This order falls under a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. As a major...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a prescription medication, to DLA facilities supporting the Department of Defense (DoD) worldwide. The delivery order has a ceiling value of $2,128.14 and a completion date of July 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up...
The Defense Logistics Agency (DLA) has awarded a $5,431.64 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as Amerisourcebergen's primary contract vehicle for delivering...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FNVR2
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products. The contract has a potential ceiling value of $5,274.05 and an ultimate completion date of July 2, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's healthcare needs worldwide. The current delivery order does not have a set-aside designation.

Generated 9/30/24, 1:09 PM